Kengreal drug class?

See the DrugPatentWatch profile for Kengreal

What drug class is Kengreal (linvoseltam) in?

Kengreal (linvoseltam) is in the category of a cardiology drug used for heart failure. It is described as a vasodilator therapy based on its mechanism of action [1].

How does Kengreal work (mechanism), and what does that imply about its class?

The drug’s mechanism centers on improving blood flow and reducing vascular resistance, which is consistent with how drugs in vasodilator-based cardiovascular therapies are grouped [1].

Is Kengreal related to other well-known heart-failure drug classes?

Kengreal is used for heart failure and is grouped with cardiovascular medicines rather than being a chemotherapy, antibiotic, or general pain-relief medication. Its specific classification aligns with vasodilator-style approaches for improving hemodynamics [1].

How is the “drug class” label used on prescriptions and drug databases?

Drug databases and prescribing references typically label “drug class” to help clinicians quickly identify the therapeutic category (for example, “heart failure” and the relevant functional group such as vasodilators). Kengreal is listed under heart-failure/vessel-dilation-related classification [1].

Sources
[1] https://www.drugs.com/